Granules India receives acclaim for Generic K-Dur

Granules India receives acclaim for Generic K-Dur

by admin- Thursday, October 22nd, 2020 04:18:50 PM

Granules India has received marketing approval from the USFDA for Potassium Chloride Extended Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg) for the treatment of sufferers with hypokalemia. Granules’ tablet product is bioequivalent to the reference indexed drug (RLD), K-Dur.

News Updates